Methotrexate Injection, Powder, Lyophilized, For Solution
Product Images NDC 0143-9367

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Methotrexate (NDC 0143-9367). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Methotrexate For Injection Usp Novaplus 1)

Chemical structure of methotrexate, showing its molecular components including multiple rings and functional groups consistent with this active ingredient.*

FDA Label Image

Methotrexate For Injection, Usp 1 G/vial Container Label (Methotrexate For Injection Usp Novaplus 2)

Methotrexate 1 g/ vial injection powder lyophilized for solution, sterile and preservative-free with cytotoxic agent warning. Single-use vial label shows dosing, storage instructions (20-25°C), and manufacturing details by Hikma Pharmaceuticals USA Inc., with a blue and white design and the 'novaplus+' logo.*

FDA Label Image

Representative Serialization Image (Methotrexate For Injection Usp Novaplus 3)

Label panel for Methotrexate 1 g injection, powder, lyophilized, for solution by Hikma Pharmaceuticals USA Inc. The label includes a data matrix barcode and printed lot number, expiration date, GTIN, and serial number information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.